These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 36593382)
21. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose. Chen W; Dilsizian V Curr Cardiol Rep; 2013 Jun; 15(6):364. PubMed ID: 23605466 [TBL] [Abstract][Full Text] [Related]
22. Atherosclerosis Imaging: Positron Emission Tomography. Ng SJ; Lau HC; Naseer R; Sandhu S; Raynor WY; Werner TJ; Alavi A PET Clin; 2023 Jan; 18(1):71-80. PubMed ID: 36442967 [TBL] [Abstract][Full Text] [Related]
23. Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer. Simoncic U; Perlman S; Liu G; Jeraj R Nucl Med Commun; 2015 Dec; 36(12):1174-80. PubMed ID: 26378490 [TBL] [Abstract][Full Text] [Related]
24. McKenney-Drake ML; Moghbel MC; Paydary K; Alloosh M; Houshmand S; Moe S; Salavati A; Sturek JM; Territo PR; Weaver C; Werner TJ; Høilund-Carlsen PF; Sturek M; Alavi A Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2190-2200. PubMed ID: 29978245 [TBL] [Abstract][Full Text] [Related]
25. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer. Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167 [TBL] [Abstract][Full Text] [Related]
26. Critical review of PET imaging for detection and characterization of the atherosclerotic plaques with emphasis on limitations of FDG-PET compared to NaF-PET in this setting. Alavi A; Werner TJ; Raynor W; Høilund-Carlsen PF; Revheim ME Am J Nucl Med Mol Imaging; 2021; 11(5):337-351. PubMed ID: 34754605 [TBL] [Abstract][Full Text] [Related]
27. The Role of PET in Evaluating Atherosclerosis: A Critical Review. Moghbel M; Al-Zaghal A; Werner TJ; Constantinescu CM; Høilund-Carlsen PF; Alavi A Semin Nucl Med; 2018 Nov; 48(6):488-497. PubMed ID: 30322475 [TBL] [Abstract][Full Text] [Related]
28. (18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis. Watanabe T; Takase-Minegishi K; Ihata A; Kunishita Y; Kishimoto D; Kamiyama R; Hama M; Yoshimi R; Kirino Y; Asami Y; Suda A; Ohno S; Tateishi U; Ueda A; Takeno M; Ishigatsubo Y Mod Rheumatol; 2016; 26(2):180-7. PubMed ID: 26140472 [TBL] [Abstract][Full Text] [Related]
29. A prospective study comparing whole-body skeletal X-ray survey with 18F-FDG-PET/CT, 18F-NaF-PET/CT and whole-body MRI in the detection of bone lesions in multiple myeloma patients. Dyrberg E; Hendel HW; Al-Farra G; Balding L; Løgager VB; Madsen C; Thomsen HS Acta Radiol Open; 2017 Oct; 6(10):2058460117738809. PubMed ID: 29123920 [TBL] [Abstract][Full Text] [Related]
31. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467 [TBL] [Abstract][Full Text] [Related]
32. Utility of 18F-fluorodeoxy glucose and 18F-sodium fluoride positron emission tomography/computed tomography in the diagnosis of medication-related osteonecrosis of the jaw: A preclinical study in a rat model. Kim Y; Lee HY; Yoon HJ; Kim BS J Craniomaxillofac Surg; 2016 Apr; 44(4):357-63. PubMed ID: 26880011 [TBL] [Abstract][Full Text] [Related]
33. Assessing the feasibility of NaF-PET/CT versus FDG-PET/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients. Seraj SM; Raynor WY; Revheim ME; Al-Zaghal A; Zadeh MZ; Arani LS; Rojulpote C; Werner TJ; Gerke O; Høilund-Carlsen PF; Baker JF; Alavi A; Hunt SJ Ann Nucl Med; 2020 Jun; 34(6):424-431. PubMed ID: 32277422 [TBL] [Abstract][Full Text] [Related]
35. [18F]FDG PET/CT in rheumatoid arthritis. Graham RN; Panagiotidis E Q J Nucl Med Mol Imaging; 2022 Sep; 66(3):234-244. PubMed ID: 36066112 [TBL] [Abstract][Full Text] [Related]
36. Quantification of temporal changes in calcium score in active atherosclerotic plaque in major vessels by Ishiwata Y; Kaneta T; Nawata S; Hino-Shishikura A; Yoshida K; Inoue T Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1529-1537. PubMed ID: 28349280 [TBL] [Abstract][Full Text] [Related]
37. Different lesions revealed by 18F-FDG PET/CT and 18F-NaF PET/CT in patients with multiple myeloma. Xu F; Liu F; Pastakia B Clin Nucl Med; 2014 Sep; 39(9):e407-9. PubMed ID: 24217536 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of Yellanki DP; Kothekar E; Al-Zaghal A; Cheng N; Werner TJ; Høilund-Carlsen PF; Alavi A Hell J Nucl Med; 2018; 21(3):181-185. PubMed ID: 30411728 [TBL] [Abstract][Full Text] [Related]
39. Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions. Capitanio S; Bongioanni F; Piccardo A; Campus C; Gonella R; Tixi L; Naseri M; Pennone M; Altrinetti V; Buschiazzo A; Bossert I; Fiz F; Bruno A; DeCensi A; Sambuceti G; Morbelli S World J Radiol; 2016 Feb; 8(2):200-9. PubMed ID: 26981229 [TBL] [Abstract][Full Text] [Related]
40. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases. Iagaru A; Mittra E; Dick DW; Gambhir SS Mol Imaging Biol; 2012 Apr; 14(2):252-9. PubMed ID: 21479710 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]